As we continue our important work for COMPPARE, we have joined national organizations in developing procedures to treat patients with prostate cancer and other malignancies safely during the COVID-19 outbreak. In addition, we are collaborating with our sites to strengthen their recruitment processes. Read more of Dr. Mendenhall’s message.
The 2020 COMPPARE Workshop in January allowed researchers and patients to cross-pollinate their ideas, and the decision to expand COMPPARE eligibility criteria was derived from the feedback of Principal Investigators who attended – learn more about the revised criteria.
Radiation oncology programs across the county are adapting to a reduction in referrals and developing new safety strategies, so what can you and your family now expect during proton therapy, IMRT or SBRT? We’ve compiled some Frequently Asked Questions to help.
Outreach Update: Site Visits Bring Study Teams Together
Presentations and important discussions with site PIs earlier this year helped us to learn new ways of increasing enrollment and COMPPARE team engagement support – follow the COMPPARE road trip.
Dr. Nancy Mendenhall discussed proton therapy with the It’s All About You Radio Show.
The COMPPARE team continues to refine social media outreach based on stakeholder feedback, patient demographics, and response to our newsletter, the COMPPARE website, and social media campaigns. Take a look at social media progress here.
“When I got the news that my test results confirmed a prostate cancer diagnosis, I was playing golf with my son and son-in-law. So for the next three and a half hours, I had to hold it together and finish the game without telling them.” Read Thomas’ journey.
Through the Prostate Health Education Network (PHEN), A.J.Merriweather organizes events for veterans twice a month at the American Legion Post 197. Find out how A.J. uses his experience to help those who serve our country.
Want the latest information on COMPPARE? Find out how many patients have enrolled and how many sites are currently enrolling patients on the COMPPARE Study Progress page.
Research reported in this newsletter was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422). The views, statements, and opinions presented in this newsletter are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or Methodology Committee.
We look forward to sharing our patient-centric news with you. Below you can find an archive of our issues and subscribe to receive COMPPARE Connection in your inbox.